Literature DB >> 32081791

Advances in the molecular mechanisms of NLRP3 inflammasome activators and inactivators.

Dongling Liu1, Xiang Zeng2, Xiao Li3, Chaochu Cui3, Ruanling Hou4, Zhikun Guo3, Jawahar L Mehta5, Xianwei Wang6.   

Abstract

NLRP3 inflammasome is an intracellular protein complex that initiates cellular injury via assembly of NLRP3, ASC and caspase-1 in response to microbial infection and sterile stressors. The importance of NLRP3 inflammasome in immunity and human diseases has been well documented. Up to now, targeted inhibition of the assembly of NLRP3 inflammasome complex and of its activation was thought to be therapeutic strategy for associated diseases. Recent studies show that a host of molecules such as NIMA-related kinase 7 (Nek7) and DEAD-box helicase 3 X-linked (DDX3X) and a large number of biological mediators including cytokines, microRNAs, nitric oxide, carbon monoxide, nuclear factor erythroid-2 related factor 2 (Nrf2) and cellular autophagy participate in the activation and inactivation of NLRP3 inflammasome. This review summarizes current understanding of the molecular basis of NLRP3 inflammasome activation and inactivation. This knowledge may lead to development of new therapies directed at NLRP3 inflammasome related diseases.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DEAD-box helicase 3 X-linked; Interleukin-1β; NIMA-related kinase 7; NLRP3 inflammasome; Therapeutic target

Year:  2020        PMID: 32081791     DOI: 10.1016/j.bcp.2020.113863

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  28 in total

Review 1.  Carbon monoxide-triggered health effects: the important role of the inflammasome and its possible crosstalk with autophagy and exosomes.

Authors:  Rong-Jane Chen; Yu-Hsuan Lee; Tzu-Hao Chen; Yu-Ying Chen; Ya-Ling Yeh; Ching-Ping Chang; Chien-Cheng Huang; How-Ran Guo; Ying-Jan Wang
Journal:  Arch Toxicol       Date:  2021-02-08       Impact factor: 5.153

2.  Expression and Mechanism of TXNIP/NLRP3 Inflammasome in Sciatic Nerve of Type 2 Diabetic Rats.

Authors:  Le Han; Guangxia Xi; Na Guo; Jing Guo; Qingfeng Rong
Journal:  Dis Markers       Date:  2022-07-08       Impact factor: 3.464

Review 3.  Role of NLRP3 Inflammasome in Rheumatoid Arthritis.

Authors:  Hui Yin; Na Liu; Keshav Raj Sigdel; Lihua Duan
Journal:  Front Immunol       Date:  2022-06-27       Impact factor: 8.786

Review 4.  The Role of the NLRP3 Inflammasome in Mediating Glomerular and Tubular Injury in Diabetic Nephropathy.

Authors:  B M Williams; C L Cliff; K Lee; P E Squires; C E Hills
Journal:  Front Physiol       Date:  2022-06-09       Impact factor: 4.755

5.  Caspase-1 has a critical role in blood-brain barrier injury and its inhibition contributes to multifaceted repair.

Authors:  Hila Israelov; Orly Ravid; Dana Atrakchi; Daniel Rand; Shirin Elhaik; Yael Bresler; Rachel Twitto-Greenberg; Liora Omesi; Sigal Liraz-Zaltsman; Fabien Gosselet; Michal Schnaider Beeri; Itzik Cooper
Journal:  J Neuroinflammation       Date:  2020-09-09       Impact factor: 8.322

Review 6.  The Nlrp3 inflammasome - the evolving story of its positive and negative effects on hematopoiesis.

Authors:  Mariusz Z Ratajczak; Magdalena Kucia
Journal:  Curr Opin Hematol       Date:  2021-07-01       Impact factor: 3.218

7.  P2X7 Receptor and Heart Function in a Mouse Model of Systemic Inflammation Due to High Fat Diet.

Authors:  Francesco Raggi; Chiara Rossi; Francesco Faita; Mariarosaria Distaso; Claudia Kusmic; Anna Solini
Journal:  J Inflamm Res       Date:  2022-04-14

Review 8.  The Nlrp3 inflammasome as a "rising star" in studies of normal and malignant hematopoiesis.

Authors:  Mariusz Z Ratajczak; Kamila Bujko; Monika Cymer; Arjun Thapa; Mateusz Adamiak; Janina Ratajczak; Ahmed K Abdel-Latif; Magda Kucia
Journal:  Leukemia       Date:  2020-04-20       Impact factor: 11.528

Review 9.  The Role of NLRP3 Inflammasome in Cerebrovascular Diseases Pathology and Possible Therapeutic Targets.

Authors:  Rongrong Bai; Yue Lang; Jie Shao; Yu Deng; Reyisha Refuhati; Li Cui
Journal:  ASN Neuro       Date:  2021 Jan-Dec       Impact factor: 4.146

10.  Astragaloside IV ameliorates diabetic nephropathy in db/db mice by inhibiting NLRP3 inflammasome‑mediated inflammation.

Authors:  Hui Feng; Xiaoyun Zhu; Yang Tang; Shouqiang Fu; Bingtan Kong; Ximing Liu
Journal:  Int J Mol Med       Date:  2021-07-19       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.